Essential oils for agitation in dementia [rELOAD]: A pragmatic, cluster-randomized, placebo-controlled, pilot feasibility trial

Background: Clinical guidelines recommend non-pharmacological interventions as the first line of treatment for agitation in dementia. One intervention that shows some promise as a treatment for agitation is essential oils. The objective of this study was to provide preliminary evidence of the effect...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Matthew J Leach, Merrian Sangalli, Ian Breakspear, Sandra Walsh
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Agitation Aromatherapy Clinical trial Dementia Quality of life Miscellaneous systems and treatments RZ409.7-999
Acceso en línea:	https://doaj.org/article/42be4b781f30466f9c427f20d1b52053
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:42be4b781f30466f9c427f20d1b52053
record_format	dspace
spelling	oai:doaj.org-article:42be4b781f30466f9c427f20d1b520532021-11-28T04:31:36ZEssential oils for agitation in dementia [rELOAD]: A pragmatic, cluster-randomized, placebo-controlled, pilot feasibility trial2213-422010.1016/j.imr.2021.100747https://doaj.org/article/42be4b781f30466f9c427f20d1b520532021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2213422021000342https://doaj.org/toc/2213-4220Background: Clinical guidelines recommend non-pharmacological interventions as the first line of treatment for agitation in dementia. One intervention that shows some promise as a treatment for agitation is essential oils. The objective of this study was to provide preliminary evidence of the effectiveness and feasibility of using topically-administered, individualized essential oil preparations for the alleviation of agitation in persons with dementia. Methods: We conducted a 10-week pragmatic, cluster-randomized, placebo-controlled, pilot feasibility trial to compare the effectiveness of topically-administered, individualized essential oil preparations to control (placebo) preparations. Outcomes included frequency and severity of agitation, quality of life, frequency of antipsychotic medication use and physical restraint, incidence of adverse events, and trial feasibility. Participants with dementia and clinically significant agitation were recruited from five residential aged-care facilities across regional South Australia. Results: Thirty-eight participants were randomized from five sites. Accounting for random effects, we found statistically significant differences between the intervention and control groups in Pittsburgh Agitation Scale (PAS) aberrant vocalization sub score, Cohen Mansfield Agitation Inventory (CMAI) verbally agitated sub score and CMAI total score at week 4, but not at weeks 8 (post-intervention) or 10 (follow-up). No significant time-group interactions were observed for other PAS/CMAI scores or sub scores, quality of life - Alzheimer's disease total score, or frequency of physical restraint or as-needed antipsychotic medication. No adverse events were reported in any group. Conclusions: The study findings highlight some promising effects of topically-administered, individualized essential oil preparations for agitation in dementia, and indicate that a large multi-center, cluster-randomized controlled trial of this treatment is feasible. Trial registration: Australian New Zealand Clinical Trial Registry [ACTRN12617001159347].Matthew J LeachMerrian SangalliIan BreakspearSandra WalshElsevierarticleAgitationAromatherapyClinical trialDementiaQuality of lifeMiscellaneous systems and treatmentsRZ409.7-999ENIntegrative Medicine Research, Vol 10, Iss 4, Pp 100747- (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Agitation Aromatherapy Clinical trial Dementia Quality of life Miscellaneous systems and treatments RZ409.7-999
spellingShingle	Agitation Aromatherapy Clinical trial Dementia Quality of life Miscellaneous systems and treatments RZ409.7-999 Matthew J Leach Merrian Sangalli Ian Breakspear Sandra Walsh Essential oils for agitation in dementia [rELOAD]: A pragmatic, cluster-randomized, placebo-controlled, pilot feasibility trial
description	Background: Clinical guidelines recommend non-pharmacological interventions as the first line of treatment for agitation in dementia. One intervention that shows some promise as a treatment for agitation is essential oils. The objective of this study was to provide preliminary evidence of the effectiveness and feasibility of using topically-administered, individualized essential oil preparations for the alleviation of agitation in persons with dementia. Methods: We conducted a 10-week pragmatic, cluster-randomized, placebo-controlled, pilot feasibility trial to compare the effectiveness of topically-administered, individualized essential oil preparations to control (placebo) preparations. Outcomes included frequency and severity of agitation, quality of life, frequency of antipsychotic medication use and physical restraint, incidence of adverse events, and trial feasibility. Participants with dementia and clinically significant agitation were recruited from five residential aged-care facilities across regional South Australia. Results: Thirty-eight participants were randomized from five sites. Accounting for random effects, we found statistically significant differences between the intervention and control groups in Pittsburgh Agitation Scale (PAS) aberrant vocalization sub score, Cohen Mansfield Agitation Inventory (CMAI) verbally agitated sub score and CMAI total score at week 4, but not at weeks 8 (post-intervention) or 10 (follow-up). No significant time-group interactions were observed for other PAS/CMAI scores or sub scores, quality of life - Alzheimer's disease total score, or frequency of physical restraint or as-needed antipsychotic medication. No adverse events were reported in any group. Conclusions: The study findings highlight some promising effects of topically-administered, individualized essential oil preparations for agitation in dementia, and indicate that a large multi-center, cluster-randomized controlled trial of this treatment is feasible. Trial registration: Australian New Zealand Clinical Trial Registry [ACTRN12617001159347].
format	article
author	Matthew J Leach Merrian Sangalli Ian Breakspear Sandra Walsh
author_facet	Matthew J Leach Merrian Sangalli Ian Breakspear Sandra Walsh
author_sort	Matthew J Leach
title	Essential oils for agitation in dementia [rELOAD]: A pragmatic, cluster-randomized, placebo-controlled, pilot feasibility trial
title_short	Essential oils for agitation in dementia [rELOAD]: A pragmatic, cluster-randomized, placebo-controlled, pilot feasibility trial
title_full	Essential oils for agitation in dementia [rELOAD]: A pragmatic, cluster-randomized, placebo-controlled, pilot feasibility trial
title_fullStr	Essential oils for agitation in dementia [rELOAD]: A pragmatic, cluster-randomized, placebo-controlled, pilot feasibility trial
title_full_unstemmed	Essential oils for agitation in dementia [rELOAD]: A pragmatic, cluster-randomized, placebo-controlled, pilot feasibility trial
title_sort	essential oils for agitation in dementia [reload]: a pragmatic, cluster-randomized, placebo-controlled, pilot feasibility trial
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/42be4b781f30466f9c427f20d1b52053
work_keys_str_mv	AT matthewjleach essentialoilsforagitationindementiareloadapragmaticclusterrandomizedplacebocontrolledpilotfeasibilitytrial AT merriansangalli essentialoilsforagitationindementiareloadapragmaticclusterrandomizedplacebocontrolledpilotfeasibilitytrial AT ianbreakspear essentialoilsforagitationindementiareloadapragmaticclusterrandomizedplacebocontrolledpilotfeasibilitytrial AT sandrawalsh essentialoilsforagitationindementiareloadapragmaticclusterrandomizedplacebocontrolledpilotfeasibilitytrial
_version_	1718408311572791296

Essential oils for agitation in dementia [rELOAD]: A pragmatic, cluster-randomized, placebo-controlled, pilot feasibility trial

Ejemplares similares